Transforming growth factor-β promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells

Cancer Research

Volumn 66, Issue 16, 2006, Pages 8007-8016

  Ao, Mingfang ^a   Williams, Karin ^b   Bhowmick, Neil A ^a,b,c   Hayward, Simon W ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P21; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE TRANSLOCATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; MALE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; PROSTATE; PROSTATIC HYPERPLASIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 33748059537     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-4451     Document Type: Article

References (55)

1. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-91.
2. Akhurst RJ, Derynck R TGF-β signaling in cancer-a double-edged sword. Trends Cell Biol 2001;11:844-51.
3. Wakefield LM, Roberts AB. TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002;12:22-9.
4. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000;275:36803-10.
5. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002;115:3193-206.
6. Dumont N, Arteaga CL. Targeting the TGFβ signaling network in human neoplasia. Cancer Cell 2003;3:531-6.
7. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36.
8. Kyprianou N. Activation of TGF-β signaUing in human prostate cancer cells suppresses tumorigenicity via deregulation of cell cycle progression and induction of caspase-1 mediated apoptosis: significance in prostate tumorigenesis. Prostate Cancer Prostatic Dis 1999;2:S18.
9. Guo Y, Kyprianou N. Restoration of transforming growth factor β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res 1999;59:1366-71.
10. Lee C, Sintich SM, Mathews EP, et al. Transforming growth factor-β in benign and malignant prostate. Prostate 1999;39:285-90.
11. Barrack ER. TGFβ in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 1997;31:61-70.
12. Ellenrieder V, Hendler SF, Boeck W, et al. Transforming growth factor I treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer ceus requiring extracellular signal-regulated kinase 2 activation. Cancer Res 2001;61:4222-8.
13. Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-β inhibits mammary tumor ceU viability, migration, and metastases. J Clin Invest 2002;109:1551-9.
14. Massague J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000;1:169-78.
15. Remy I, Montmarquette A, Michnick SW. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 2004;6:358-65.
16. Conery AR, Cao Y, Thompson EA, et al. Akt interacts directly with SmadS to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol 2004;6:366-72.
17. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000;346 Pt 3:561-76.
18. Nicholson KM, Anderson NG. The protein kinase B/Akt signaUing pathway in human malignancy. Cell Signal 2002;14:381-95.
19. Danielpour D. Functions and regulation of transforming growth factor-β (TGF-β) in the prostate. Eur J Cancer 2005;41:846-57.
20. Hayward SW, Wang Y, Cao M, et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001;61:8135-42.
21. Phillips JL, Hayward SW, Wang Y, et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001;61:8143-9.
22. Hayward SW, Dahiya R, Cunha GR, et al. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim 1995;31:14-24.
23. Wieser R, Wrana JL, Massague J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 1995;14:2199-208.
24. Barthel A, Kohn AD, Luo Y, Roth RA. A constitutively active version of the Ser/Thr kinase Akt induces production of the ob gene product, leptin, in 3T3-1 adipocytes. Endocrinology 1997;138:3559-62.
25. Bernard DJ. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone β subunit in mouse gonadotrope cells. Mol Endocrinol 2004;18:606-23.
26. Williams K, Fernandez S, Stien X, et al. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate 2005;63:369-84.
27. Liu X, Yue J, Frey RS, Zhu Q, Mulder KM. Transforming growth factor β signaling through Smad1 in human breast cancer cells. Cancer Res 1998;58:4752-7.
28. Nagarajan RP, Chen F, Li W, et al. Repression of transforming-growth- factor-mediated transcription by nuclear factor κB. Biochem J 2000;348 Pt 3:591-6.
29. Mochizuki H, Matsubara A, Teishima J, et al. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Biochem Biophys Res Commun 2004;320:656-63.
30. Song K, Cornelius SC, Reiss M, Danielpour D. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-β by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 2003;278:38342-51.
31. Olumi AF, Grossfeld GD, Hayward SW, et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-11.
32. Piek E, Roberts AB. Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis. Adv Cancer Res 2001;83:1-54.
33. Song K, Wang H, Krebs TL, Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J 2006;25:58-69.
34. Wakefield LM, Piek E, Bottinger EP. TGF-β signaling in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2001;6:67-82.
35. Bello-DeOcampo D, Tindall DJ. TGF-β1/Smad signaling in prostate cancer. Curr Drug Targets 2003;4:197-207.
36. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
37. Wikstrom P, Damber J, Bergh A. Role of transforming growth factor-β1 in prostate cancer. Microsc Res Tech 2001;52:411-9.
38. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003;425:577-84.
39. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999;96:4240-5.
40. Davies MA, Koul D, Dhesi H, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 1999;59:2551-6.
41. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
42. Reynisdottir I, Polyak K, lavarone A, Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 1995;9:1831-45.
43. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett 2002;82:85-91.
44. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995;154:8-20.
45. Guo Y, Kyprianou N. Overexpression of transforming growth factor (TGF) β1 type II receptor restores TGF-β1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ 1998;9:185-93.
46. Yue J, Mulder KM. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-β. Methods Mol Biol 2000;142:125-31.
47. Miettinen PJ, Ebner R, Lopez AR, Derynck R TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994;127:2021-36.
48. Bhowmick NA, Chytil A, Plieth D, et al. TGF-β signaling in fibrobliists modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848-51.
49. Janda E, Lehmann K, Killisch I, et al. Ras and TGF7beta; cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002;156:299-313.
50. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 2005;65:5769-77.
51. Yasunaga Y, Nakamura K, Ko D, et al. A novel human cancer culture model for the study of prostate cancer. Oncogene 2001;20:8036-41.
52. Dalrymple S, Antony L, Xu Y, et al. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Cancer Res 2005;65:9269-79.
53. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997;18:1215-23.
54. Brown KA, Aakre ME, Gorska AE, et al. Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 2004;6:R215-31.
55. Wikstrom P, Stattin P, Franck-Lissbrant I, Damber JE, Bergh A. Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 1998;37:19-29.